Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

HealthLynked (HLYK) Non-Current Deferred Tax Liability (2020 - 2024)

Historic Non-Current Deferred Tax Liability for HealthLynked (HLYK) over the last 5 years, with Q4 2024 value amounting to $9.9 million.

  • HealthLynked's Non-Current Deferred Tax Liability rose 1061.75% to $9.9 million in Q4 2024 from the same period last year, while for Dec 2024 it was $9.9 million, marking a year-over-year increase of 1061.75%. This contributed to the annual value of $9.9 million for FY2024, which is 1061.75% up from last year.
  • Latest data reveals that HealthLynked reported Non-Current Deferred Tax Liability of $9.9 million as of Q4 2024, which was up 1061.75% from $8.9 million recorded in Q4 2023.
  • Over the past 5 years, HealthLynked's Non-Current Deferred Tax Liability peaked at $9.9 million during Q4 2024, and registered a low of $4.7 million during Q4 2020.
  • For the 5-year period, HealthLynked's Non-Current Deferred Tax Liability averaged around $7.5 million, with its median value being $8.8 million (2022).
  • As far as peak fluctuations go, HealthLynked's Non-Current Deferred Tax Liability skyrocketed by 7414.93% in 2022, and later skyrocketed by 116.9% in 2023.
  • HealthLynked's Non-Current Deferred Tax Liability (Quarter) stood at $4.7 million in 2020, then increased by 6.78% to $5.1 million in 2021, then surged by 74.15% to $8.8 million in 2022, then rose by 1.17% to $8.9 million in 2023, then grew by 10.62% to $9.9 million in 2024.
  • Its last three reported values are $9.9 million in Q4 2024, $8.9 million for Q4 2023, and $8.8 million during Q4 2022.